Raie Bekele
@raiebekele.bsky.social
Experimental Oncologist | @DanaFarber & @HarvardMed | Expert in DNA Repair & MAPK Signaling | Focused on Solid Tumors | Views are my own.
A protease-activated nanosensor blood test enables early detection of pancreatic cancer. | Science Translational Medicine www.science.org/doi/10.1126/...
Early detection of pancreatic cancer by a high-throughput protease-activated nanosensor assay
A high-throughput, noninvasive, rapid protease-activated nanosensor identifies patients with pancreatic cancer in a small volume of blood.
www.science.org
February 13, 2025 at 9:50 AM
A protease-activated nanosensor blood test enables early detection of pancreatic cancer. | Science Translational Medicine www.science.org/doi/10.1126/...
Reposted by Raie Bekele
A combination treatment has translational potential in immunoresistant tumors! https://www.jci.org/articles/view/180278
Allison Joy Nielsen et al. show pharmacological inhibition of the DNA/protein kinase interaction induces sensitivity to immune checkpoint blockade in melanoma models.
Allison Joy Nielsen et al. show pharmacological inhibition of the DNA/protein kinase interaction induces sensitivity to immune checkpoint blockade in melanoma models.
December 26, 2024 at 2:20 PM
A combination treatment has translational potential in immunoresistant tumors! https://www.jci.org/articles/view/180278
Allison Joy Nielsen et al. show pharmacological inhibition of the DNA/protein kinase interaction induces sensitivity to immune checkpoint blockade in melanoma models.
Allison Joy Nielsen et al. show pharmacological inhibition of the DNA/protein kinase interaction induces sensitivity to immune checkpoint blockade in melanoma models.
Reposted by Raie Bekele
🎯Cancer Cell Review 2024
Myeloid effector cells in cancer
"the key role of myeloid effector cells in tumor rejection"
www.cell.com/cancer-cell/...
Myeloid effector cells in cancer
"the key role of myeloid effector cells in tumor rejection"
www.cell.com/cancer-cell/...
December 17, 2024 at 4:25 PM
🎯Cancer Cell Review 2024
Myeloid effector cells in cancer
"the key role of myeloid effector cells in tumor rejection"
www.cell.com/cancer-cell/...
Myeloid effector cells in cancer
"the key role of myeloid effector cells in tumor rejection"
www.cell.com/cancer-cell/...
Reposted by Raie Bekele
The Massachusetts Society of Clinical Oncologists (MSCO) Board of Directors has honored Geoffrey Shapiro, MD, PhD, with this year's MSCO Distinguished Researcher Award. Congratulations, Geoffrey, on this notable recognition!
December 16, 2024 at 9:05 PM
The Massachusetts Society of Clinical Oncologists (MSCO) Board of Directors has honored Geoffrey Shapiro, MD, PhD, with this year's MSCO Distinguished Researcher Award. Congratulations, Geoffrey, on this notable recognition!
Reposted by Raie Bekele
A special thanks to our Networking Mixer panelists—Drs. Kristala Prather, Kimberly Stegmaier, Richa Saxena, Aaron Moye, Abraham Cessay, Grace Silva, Tom Thomas, David Alagpulinsa, Nisha Iyer, & Biniam Adane—for making the evening so impactful.
December 14, 2024 at 12:03 AM
A special thanks to our Networking Mixer panelists—Drs. Kristala Prather, Kimberly Stegmaier, Richa Saxena, Aaron Moye, Abraham Cessay, Grace Silva, Tom Thomas, David Alagpulinsa, Nisha Iyer, & Biniam Adane—for making the evening so impactful.